Published Randomized Comparative Data Demonstrate Superior Outcomes with Dayspring in Adults Aged 65 and Older and Patients with Phlebolymphedema
Findings extend published head-to-head evidence for Dayspring across two clinically important lower-extremity lymphedema populations. DALLAS, July 23, 2026 /PRNewswire/ -- Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic...
Findings extend published head-to-head evidence for Dayspring across two clinically important lower-extremity lymphedema populations. DALLAS, July 23, 2026 /PRNewswire/ -- Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.